Cargando…
Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
Splicing abnormalities frequently occur in cancer. A key role as splice site choice regulator is played by the members of the SR (Ser/Arg-rich) family of proteins. We recently demonstrated that SRSF2 is involved in cisplatin-mediated apoptosis of human lung carcinoma cell lines. In this study, by us...
Autores principales: | Gout, Stephanie, Brambilla, Elisabeth, Boudria, Asma, Drissi, Romain, Lantuejoul, Sylvie, Gazzeri, Sylvie, Eymin, Beatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468597/ https://www.ncbi.nlm.nih.gov/pubmed/23071587 http://dx.doi.org/10.1371/journal.pone.0046539 |
Ejemplares similares
-
FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells
por: Jia, Tao, et al.
Publicado: (2021) -
A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells
por: Abou Faycal, Cherine, et al.
Publicado: (2019) -
Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells
por: Gonçalves, Vânia, et al.
Publicado: (2014) -
SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma
por: Liu, Hongda, et al.
Publicado: (2021) -
Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
por: Wagner, Kay-Dietrich, et al.
Publicado: (2019)